Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 10950946)

Published in Blood Cells Mol Dis on June 01, 2000

Authors

D A Scott1, J A Stapleton, R F Wilson, G Sutherland, R M Palmer, P Y Coward, G Gustavsson

Author Affiliations

1: Dental Clinical Research, King's College London, London, United Kingdom. david.2.scott@kcl.ac.uk

Articles by these authors

Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (1986) 9.93

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol (1990) 8.85

Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A (1989) 8.34

Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci U S A (1989) 7.79

Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol (1989) 6.87

A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol (1989) 6.30

Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA (2001) 6.02

Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol (1990) 5.87

Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol (1987) 5.23

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol (1987) 4.88

Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet (1987) 4.55

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A (1990) 4.49

Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J Pharmacol (1986) 4.23

Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol (1988) 4.16

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A (1990) 3.98

A prospective study to investigate the relationship between periodontal disease and adverse pregnancy outcome. Br Dent J (2004) 3.96

A randomized trial of care in a hospital medical unit especially designed to improve the functional outcomes of acutely ill older patients. N Engl J Med (1995) 3.77

Relation between symptoms of depression and health status outcomes in acutely ill hospitalized older persons. Ann Intern Med (1997) 3.76

Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J (1989) 3.70

Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ (1999) 3.61

The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun (1987) 3.25

Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A (1991) 3.22

Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med (1998) 3.21

Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun (1990) 3.14

Chest pain in cardiac-transplant recipients. Evidence of sensory reinnervation after cardiac transplantation. N Engl J Med (1991) 2.96

Control of regional blood flow by endothelium-derived nitric oxide. Hypertension (1990) 2.93

Functional status before hospitalization in acutely ill older adults: validity and clinical importance of retrospective reports. J Am Geriatr Soc (2000) 2.92

Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ (1993) 2.91

A new trichrome-blue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens. J Clin Microbiol (1993) 2.77

Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem Biophys Res Commun (1989) 2.73

Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction (1995) 2.71

Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evid Rep Technol Assess (Summ) (2005) 2.69

Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol (1989) 2.68

Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis (1992) 2.63

Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species. Prostaglandins (1980) 2.59

NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol (1989) 2.53

Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J (1999) 2.44

Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet (1992) 2.44

Measuring prognosis and case mix in hospitalized elders. The importance of functional status. J Gen Intern Med (1997) 2.42

Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br J Pharmacol (1988) 2.32

District programme to reduce smoking: effect of clinic supported brief intervention by general practitioners. Br Med J (Clin Res Ed) (1987) 2.29

Partial purification of the template-active fraction of chromatin: a preliminary report. Proc Natl Acad Sci U S A (1974) 2.25

Effects of a multicomponent intervention on functional outcomes and process of care in hospitalized older patients: a randomized controlled trial of Acute Care for Elders (ACE) in a community hospital. J Am Geriatr Soc (2000) 2.20

Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci U S A (1993) 2.10

Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. Eur Respir J (1996) 2.03

Can a workplace preventive programme affect periodontal health? Br Dent J (1998) 2.03

Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A (1986) 2.03

Prospective study of factors predicting uptake of smoking in adolescents. J Epidemiol Community Health (1989) 2.01

The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension (1988) 2.00

Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet (1992) 2.00

Kinetic characteristics of nitric oxide synthase from rat brain. Biochem J (1990) 2.00

Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo. Circulation (1992) 1.97

Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol (1991) 1.96

Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure, and ventricular preload. Circulation (1990) 1.91

A radioimmunoassay for leukotriene B4. Prostaglandins (1982) 1.86

Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med (1995) 1.85

Characterization of Chloroplasts Isolated from Triazine-Susceptible and Triazine-Resistant Biotypes of Brassica campestris L. Plant Physiol (1982) 1.79

End-diastolic volume. A better indicator of preload in the critically ill. Arch Surg (1992) 1.77

Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol (1990) 1.72

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer (1999) 1.71

Characteristics and outcomes of patients who self-extubate from ventilatory support: a case-control study. Chest (1997) 1.70

The prevalence of tooth wear in a cluster sample of adolescent schoolchildren and its relationship with potential explanatory factors. Br Dent J (1998) 1.65

Depressive symptoms and 3-year mortality in older hospitalized medical patients. Ann Intern Med (1999) 1.64

How much does relapse after one year erode effectiveness of smoking cessation treatments? Long-term follow up of randomised trial of nicotine nasal spray. BMJ (1998) 1.63

Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol (1990) 1.62

Effect of increased intra-abdominal pressure on hepatic arterial, portal venous, and hepatic microcirculatory blood flow. J Trauma (1992) 1.60

Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart. Cardiovasc Res (1992) 1.57

Effects of functional status changes before and during hospitalization on nursing home admission of older adults. J Gerontol A Biol Sci Med Sci (1999) 1.56

Studies on Genetic Male-Sterile Soybeans : II. Effect of Nodulation on Photosynthesis and Carbon Partitioning in Leaves. Plant Physiol (1983) 1.56

High resolution characterization of an interstitial deletion of less than 1.9 Mb at 4p16.3 associated with Wolf-Hirschhorn syndrome. Am J Med Genet (1997) 1.56

Perceived sources of occupational stress in general dental practitioners. Br Dent J (1998) 1.51

Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol (2003) 1.49

Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48

Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology (1997) 1.48

The role of major gene in clubfoot. Am J Hum Genet (1988) 1.46

Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans. Circulation (1995) 1.42

Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline. J Biol Chem (1991) 1.42

Novel subgingival bacterial phylotypes detected using multiple universal polymerase chain reaction primer sets. Oral Microbiol Immunol (2006) 1.42

Adjunctive systemic and locally delivered metronidazole in the treatment of periodontitis: a controlled clinical study. Br Dent J (1998) 1.42

Pulmonary contusions: quantifying the lesions on chest X-ray films and the factors affecting prognosis. J Trauma (1999) 1.42

Caveat emptor: a clinician's guide to assessing the physiologic significance of arterial stenoses. Cathet Cardiovasc Diagn (1993) 1.41

The management of developmentally absent maxillary lateral incisors--a survey of orthodontists in the UK. Br Dent J (2007) 1.41

A re-evaluation of electrical resistance measurements for the diagnosis of occlusal caries. Br Dent J (1995) 1.41

Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb (1991) 1.39

Anterior chamber microsurgery. Trans Aust Coll Ophthalmol (1969) 1.39

The controversies in cardiopulmonary resuscitation on high-dose epinephrine still continue. Crit Care Med (1994) 1.39

Börjeson-Forssman-Lehmann syndrome: clinical manifestations and gene localization to Xq26-27. Am J Med Genet (1989) 1.38

Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet (1992) 1.38

Experimental atrial septal defect closure with a new, transcatheter, self-centering device. Circulation (1993) 1.36

Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol (1990) 1.36

The relation between health status changes and patient satisfaction in older hospitalized medical patients. J Gen Intern Med (1998) 1.35

Protein synthesis in isolated rabbit forelimb muscles. The possible role of metabolites of arachidonic acid in the response to intermittent stretching. Biochem J (1983) 1.35

Establishing a case-finding and referral system for at-risk older individuals in the emergency department setting: the SIGNET model. J Am Geriatr Soc (2001) 1.34

Nonpenetrating thoracic injuries. Surg Clin North Am (1977) 1.34